Skip to Content

'
Gildy V. Babiera, MD, FACS

Present Title & Affiliation

Primary Appointment

Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1991 New York Medical College, Valhalla, NY, MD, Medicine
1986 Duke University, Durham, NC, BA, Chemistry and Economics, Cum Laude

Postgraduate Training

1996-1997 Clinical Residency, General Surgery, New York University Medical Center, New York, NY
1995-1996 Clinical Research Fellowship, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
1994-1995 Clinical Residency, General Surgery, New York University Medical Center, New York, NY
1992-1993 Clinical Residency, General Surgery, New York University Medical Center, New York, NY
1991-1992 Clinical Internship, General Surgery, New York University Medical Center, New York, NY

Honors and Awards

2011 Silver Award for Accelerated Partial Breast Irradiation (APBI) Video, National Health Information Awards
2010 Best Studies of the Month, Senology Oncology and Women's Health
2008 Best Studies of the Year, Brian Badgwell, MD (Awarded to Mentee), Science Daily, University of Texas MD Anderson Cancer Center
2008 Outstanding ACOSOG Z1031 Trial Enrollment Award
2007 Conquer Cancer Foundation of ASCO Merit Award - Julie Lang, MD (Awarded to Mentee), American Society of Clinical Oncology Annual Meeting
2007 Conquer Cancer Foundation of ASCO Merit Award - Regina Fearmonti, MD (Awarded to Mentee), American Society of Clinical Oncology Breast Cancer Symposium
2006 Who's Who in America, Marquis
2005-2011 In Recognition of Distinguished Contributions to the Work of the Commission on Cancer, American College of Surgeons
2005 Best Doctors in America, Castle Connolly Top Doctors
1991 Alpha Omega Alpha Honor Society
1991 American Medical Womens Association Scholarship Award
1991 Cor et Manus Award of Distinction
1991 Janet M. Glasgow Memorial Achievement Citation
1991 New York Medical College Trustee Scholarship Award
1986 Duke Undergraduate Scholarship, Duke University
1986 Graduated Cum Laude, Duke University
1986 Graduated with Distinction in Chemistry, Duke University
1986 Honors Thesis in Calorimetric Studies of Alumni, Duke University

Professional Memberships

American College of Surgeons, Chicago, IL
Member, 1997
Southwest Oncology Group, San Antonio, TX
Group Member, Breast Cancer Committee and Breast Cancer Committee Working Group, 2011-present
Member, 2011

Selected Publications

Peer-Reviewed Original Research Articles

1. Caudle AS, Yi M, Hoffman KE, Mittendorf EA, Babiera GV, Hwang RF, Meric-Bernstam F, Sahin AA, Hunt KK. Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients. Ann Surg Oncol 21(1):60-5, 1/2014. e-Pub 9/2013. PMID: 24046126.
2. Wisniewski WR, Fournier KF, Ling YK, Slack RS, Babiera G, Grubbs EG, Moore LJ, Fleming JB, You YN. A focused curriculum in surgical oncology for the third-year medical students. J Surg Res 185(2):555-60, 12/2013. e-Pub 7/2013. PMID: 23845865.
3. Fitzsullivan E, Lari SA, Smith B, Caudle AS, Krishnamurthy S, Lucci A, Mittendorf EA, Babiera GV, Black DM, Wagner JL, Bedrosian I, Woodward W, Gainer SM, Hwang R, Meric-Bernstam F, Hunt KK, Kuerer HM. Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted? Ann Surg Oncol 20(13):4103-12, 12/2013. e-Pub 8/2013. PMID: 23975313.
4. Meric-Bernstam F, Rasmussen JC, Krishnamurthy S, Tan IC, Zhu B, Wagner JL, Babiera GV, Mittendorf EA, Sevick-Muraca EM. Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents. Biomed Opt Express 5(1):183-96, 12/2013. e-Pub 12/2013. PMCID: PMC3891331.
5. Gould DJ, Hunt KK, Liu J, Kuerer HM, Crosby MA, Babiera G, Kronowitz SJ. Impact of surgical techniques, biomaterials, and patient variables on rate of nipple necrosis after nipple-sparing mastectomy. Plast Reconstr Surg 132(3):330e-8e, 9/2013. PMID: 23985644.
6. Lang JE, Tereffe W, Mitchell MP, Rao R, Feng L, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Hortobagyi GN, Babiera GV. Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival. Ann Surg Oncol 20(6):1893-9, 6/2013. e-Pub 1/2013. PMID: 23306905.
7. Mittendorf EA, Buchholz TA, Tucker SL, Meric-Bernstam F, Kuerer HM, Gonzalez-Angulo AM, Bedrosian I, Babiera GV, Hoffman K, Yi M, Ross MI, Hortobagyi GN, Hunt KK. Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy. Ann Surg 257(2):173-9, 2/2013. PMID: 23291658.
8. Skinner HD, Strom EA, Motwani SB, Woodward WA, Green MC, Babiera G, Booser DJ, Meric-Bernstam F, Buchholz TA. Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy. Radiat Oncol 8:13, 2013. e-Pub 1/2013. PMCID: PMC3552737.
9. Kong AL, Tereffe W, Hunt KK, Yi M, Kang T, Weatherspoon K, Mittendorf EA, Bedrosian I, Hwang RF, Babiera GV, Buchholz TA, Meric-Bernstam F. Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer. Cancer 118(24):6287-96, 12/2012. e-Pub 5/2012. PMID: 22648744.
10. Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, Arun BK, Lucci A, Babiera GV, Wagner JL, Caudle AS, Meric-Bernstam F, Hwang RF, Bedrosian I, Hunt KK, Kuerer HM. Biology, treatment, and outcome in very young and older women with DCIS. Ann Surg Oncol 19(12):3777-84, 11/2012. e-Pub 5/2012. PMID: 22622473.
11. Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A, Kuerer HM, Meric-Bernstam F, Shah R, Babiera GV, Sahin AA, Mittendorf EA. American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns. Ann Surg Oncol 19(10):3144-51, 10/2012. e-Pub 7/2012. PMID: 22847123.
12. Kuerer HM, Lari SA, Arun BK, Hu CY, Brewster A, Mittendorf EA, Albarracin CT, Babiera GV, Caudle AS, Wagner JL, Litton JK, Bedrosian I, Meric-Bernstam F, Lucci A, Hunt KK. Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. Breast Cancer Res Treat 133(3):1131-41, 6/2012. e-Pub 3/2012. PMID: 22392043.
13. Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, Ng S, Lin L, Crowder R, Snider J, Ballman K, Weber J, Chen K, Koboldt DC, Kandoth C, Schierding WS, McMichael JF, Miller CA, Lu C, Harris CC, McLellan MD, Wendl MC, DeSchryver K, Allred DC, Esserman L, Unzeitig G, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Leitch M, Hunt K, Olson J, Tao Y, Maher CA, Fulton LL, Fulton RS, Harrison M, Oberkfell B, Du F, Demeter R, Vickery TL, Elhammali A, Piwnica-Worms H, McDonald S, Watson M, Dooling DJ, Ota D, Chang LW, Bose R, Ley TJ, Piwnica-Worms D, Stuart JM, Wilson RK, Mardis ER. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 486(7403):353-60, 6/2012. e-Pub 6/2012.
14. Wagner JL, Fearmonti R, Hunt KK, Hwang RF, Meric-Bernstam F, Kuerer HM, Bedrosian I, Crosby MA, Baumann DP, Ross MI, Feig BW, Krishnamurthy S, Hernandez M, Babiera GV. Prospective evaluation of the nipple-areola complex sparing mastectomy for risk reduction and for early-stage breast cancer. Ann Surg Oncol 19(4):1137-44, 4/2012. e-Pub 10/2011. PMID: 21979111.
15. Akay CL, Meric-Bernstam F, Hunt KK, Grubbs EG, Bedrosian I, Tucker SL, Kuerer HM, Hoffman KE, Babiera GV, Strom EA, Buchholz TA, Mittendorf EA. Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy. Ann Surg Oncol 19(3):901-7, 3/2012. e-Pub 8/2011. PMID: 21861223.
16. Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV, Kuerer HM, Hwang RF. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg 255(1):109-15, 1/2012. PMID: 22167004.
17. Dominici LS, Mittendorf EA, Wang X, Liu J, Kuerer HM, Hunt KK, Brewster A, Babiera GV, Buchholz TA, Meric-Bernstam F, Bedrosian I. Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy. Breast Cancer Res 14(3):R82, 2012. e-Pub 5/2012. PMCID: PMC3446345.
18. Caudle AS, Hunt KK, Kuerer HM, Meric-Bernstam F, Lucci A, Bedrosian I, Babiera GV, Hwang RF, Ross MI, Feig BW, Hoffman K, Litton JK, Sahin AA, Yang W, Hortobagyi GN, Buchholz TA, Mittendorf EA. Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A practice-changing trial. Ann Surg Oncol 18(9):2407-12, 9/2011. PMID: 21327455.
19. Van Leeuwen BL, Rosenkranz KM, Feng LL, Bedrosian I, Hartmann K, Hunt KK, Kuerer HM, Ross M, Singletary SE, Babiera GV. The effect of under-treatment of breast cancer in women 80 years of age and older. Crit Rev Oncol Hematol 79(3):315-20, 9/2011. e-Pub 7/2010. PMID: 20655242.
20. Wagner JL, Warneke CL, Mittendorf EA, Bedrosian I, Babiera GV, Kuerer HM, Hunt KK, Yang W, Sahin AA, Meric-Bernstam F. Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg 254(1):119-24, 7/2011. PMID: 21494124.
21. Sharma R, Rourke LL, Kronowitz SJ, Oh JL, Lucci A, Litton JK, Robb GL, Babiera GV, Mittendorf EA, Hunt KK, Kuerer HM. Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapy. Plast Reconstr Surg 127(5):1763-72, 5/2011. PMID: 21532405.
22. Yi M, Kronowitz SJ, Meric-Bernstam F, Feig BW, Symmans WF, Lucci A, Ross MI, Babiera GV, Kuerer HM, Hunt KK. Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer 117(5):916-24, 3/2011. e-Pub 10/2010. PMID: 20945319.
23. Cohen L, Chen Z, Arun B, Shao Z, Dryden M, Xu L, Le-Petross C, Dogan B, McKenna BJ, Markman M, Babiera G. External qigong therapy for women with breast cancer prior to surgery. Integr Cancer Ther 9(4):348-53, 12/2010. PMID: 21106615.
24. Valero V, Kong AL, Hunt KK, Yi M, Hwang RF, Meric-Bernstam F, Bedrosian I, Ross MI, Babiera GV, Litton JK, Mittendorf EA. Sentinel lymph node dissection is technically feasible in older breast cancer patients. Clin Breast Cancer 10(6):477-82, 12/2010. PMID: 21147692.
25. Wagner J, Boughey JC, Garrett B, Babiera G, Kuerer H, Meric-Bernstam F, Singletary E, Hunt KK, Middleton LP, Bedrosian I. Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer. Am J Surg 198(3):387-91, 9/2009. e-Pub 4/2009.
26. Krishnamurthy S, Meric-Bernstam F, Lucci A, Hwang RF, Kuerer HM, Babiera G, Ames FC, Feig BW, Ross MI, Singletary E, Hunt KK, Bedrosian I. A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer 115(7):1555-62, 4/2009.
27. Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, Hylton NM, Middleton LP, Krishnamurthy S, Perkins GH, Babiera G, Edgerton ME, Czerniecki BJ, Arun BK, Hortobagyi GN. Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol 27(2):279-88, 1/2009.
28. Badgwell BD, Giordano SH, Duan Z, Fang S, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera G. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 26(15):2482-8, 5/2008. e-Pub 4/2008. PMID: 18427152.
29. Babiera GV, Rao R, Feng L, Meric-Bernstam F, Kuerer HM, Singletary SE, Hunt KK, Ross MI, Gwyn KM, Feig BW, Ames FC, Hortobagyi GN. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 13:776-82, 6/2006. PMID: 16614878.
30. Lambert LA, Ayers GD, Hwang RF, Hunt KK, Ross MI, Kuerer HM, Singletary SE, Babiera GV, Ames FC, Feig B, Lucci A, Krishnamurthy S, Meric-Bernstam F. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 13:310-20, 3/2006. PMID: 16463073.
31. Chagpar AB, Middleton LP, Sahin AA, Dempsey P, Buzdar AU, Mirza AN, Ames FC, Babiera GV, Feig BW, Hunt KK, Kuerer HM, Meric-Bernstam F, Ross MI, Singletary SE. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg Oncol 243:257-64, 2/2006. PMID: 16432360.
32. Davis WG, Hennessy B, Babiera G, Hunt K, Valero V, Buchholz TA, Sneige N, Gilcrease MZ. Metaplastic sarcomatoid carcinoma of the breast with absent or minimal overt invasive carcinomatous component: a misnomer. Am J Surg Pathol 29:1456-63, 11/2005. PMID: 16224212.
33. Al-Refaie W, Kuerer HM, Khuwaja A, Perry A, Hunt KK, Feig B, Ames F, Ross M, Singletary SE, Meric-Bernstam F, Babiera GV. Determinants of mastectomy in breast conservation therapy candidates. Am J Surg 190:602-5, 10/2005. PMID: 16164931.
34. Raut CP, Hunt KK, Akins JS, Daley MD, Ross MI, Singletary SE, Marshall GD, Jr, Meric-Bernstam F, Babiera G, Feig BW, Ames FC, Kuerer HM. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer 104:692-9, 8/2005. PMID: 15981283.
35. Shen J, Hunt KK, Mirza NQ, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Ross MI, Ames FC, Feig BW, Singletary SE, Cristofanilli M, Meric-Bernstam F. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence. Cancer 104:479-90, 8/2005. PMID: 15968686.
36. Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM, Babiera GV, Ames FC, Sahin AA, Meric-Bernstam F. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cancer 104:20-9, 7/2005. PMID: 15912514.
37. Kawase K, Dimaio DJ, Tucker SL, Buchholz TA, Ross MI, Feig BW, Kuerer HM, Meric-Bernstam F, Babiera G, Ames FC, Singletary SE, Hunt KK. Paget's disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol 12:391-7, 5/2005. PMID: 15915373.
38. Shahar KH, Buchholz TA, Delpassand E, Sahin AA, Ross MI, Ames FC, Kuerer HM, Feig BW, Meric-Bernstam F, Babiera GV, Singletary SE, Akins JS, Mirza NQ, Hunt KK. Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma. Cancer 103:1323-9, 4/2005. PMID: 15726547.
39. Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HM. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200:516-26, 4/2005. PMID: 15804465.
40. Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW, Sahin AA, Arun B, Meric-Bernstam F. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer 101:1977-86, 11/2004. PMID: 15389473.
41. Tseng JF, Kronowitz SJ, Sun CC, Perry AC, Hunt KK, Babiera GV, Newman LA, Singletary SE, Mirza NQ, Ames FC, Meric-Bernstam F, Ross MI, Feig BW, Robb GL, Kuerer HM. The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer 101:1514-23, 10/2004. PMID: 15378473.
42. Shen J, Valero V, Buchholz TA, Singletary SE, Ames FC, Ross MI, Cristofanilli M, Babiera GV, Meric-Bernstam F, Feig B, Hunt KK, Kuerer HM. Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol 11:854-60, 9/2004. PMID: 15313733.
43. Shen J, Hunt KK, Mirza NQ, Krishnamurthy S, Singletary SE, Kuerer HM, Meric-Bernstam F, Feig B, Ross MI, Ames FC, Babiera GV. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer 101:1330-7, 9/2004. PMID: 15316905.
44. Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Feig BW, Ames FC, Babiera GV. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge. Cancer 101:508-17, 8/2004. PMID: 15274063.
45. Kronowitz SJ, Hunt KK, Kuerer HM, Babiera G, McNeese MD, Buchholz TA, Strom EA, Robb GL. Delayed-immediate breast reconstruction. Plast Reconstr Surg 113:1617-28, 5/2004. PMID: 15114121.
46. Yen TW, Hunt KK, Mirza NQ, Thomas ES, Singletary SE, Babiera GV, Meric-Bernstam F, Buchholz TA, Feig BW, Ross MI, Ames FC, Theriault RL, Kuerer HM. Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. Cancer 100:942-9, 3/2004. PMID: 14983489.
47. Raut CP, Daley MD, Hunt KK, Akins J, Ross MI, Singletary SE, Marshall GD, Jr, Meric-Bernstam F, Babiera G, Feig BW, Ames FC, Kuerer HM. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol 22:567-8, 2/2004. PMID: 14752082.
48. Pawlik TM, Perry A, Strom EA, Babiera GV, Buchholz TA, Singletary E, Perkins GH, Ross MI, Schecter NR, Meric-Bernstam F, Ames FC, Hunt KK, Kuerer HM. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer 100:490-8, 2/2004. PMID: 14745864.
49. Chagpar A, Yen T, Sahin A, Hunt KK, Whitman GJ, Ames FC, Ross MI, Meric-Bernstam F, Babiera GV, Singletary SE, Kuerer HM. Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. Am J Surg 186:371-7, 10/2003. PMID: 14553853.
50. Chagpar A, Meric-Bernstam F, Hunt KK, Ross MI, Cristofanilli M, Singletary SE, Buchholz TA, Ames FC, Marcy S, Babiera G, Feig BW, Hortobagyi GN, Kuerer HM. Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol 10:628-34, 7/2003. PMID: 12839847.
51. Hwang RF, Krishnamurthy S, Hunt KK, Mirza N, Ames FC, Feig B, Kuerer HM, Singletary SE, Babiera G, Meric F, Akins JS, Neely J, Ross MI. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10:248-54, 4/2003. PMID: 12679309.
52. Fornage BD, Sneige N, Ross MI, Mirza AN, Kuerer HM, Edeiken BS, Ames FC, Newman LA, Babiera GV, Singletary SE. Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 231:215-24, 4/2003. PMID: 14990810.
53. Diaz LK, Hunt K, Ames F, Meric F, Kuerer H, Babiera G, Ross M, Singletary E, Middleton LP, Symmans WF, Krishnamurthy S, Sahin A, Sneige N, Gilcrease MZ. Histologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol 27:385-9, 3/2003. PMID: 12604895.
54. Cabioglu N, Hunt KK, Singletary SE, Stephens TW, Marcy S, Meric F, Ross MI, Babiera GV, Ames FC, Kuerer HM. Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge. J Am Coll Surg 196:354-64, 3/2003. PMID: 12648684.
55. Kuerer HM, Thompson PA, Krishnamurthy S, Fritsche HA, Marcy SM, Babiera GV, Singletary SE, Cristofanilli M, Sneige N, Hunt KK. High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. Clin Cancer Res 9:601-5, 2/2003. PMID: 12576424.
56. Vlastos G, Mirza NQ, Meric F, Hunt KK, Mirza AN, Newman LA, Ames FC, Kuerer HM, Ross MI, Feig B, Babiera G, Buchholz TA, Hortobagyi GN, Singletary SE. Breast-conservation therapy in early-stage breast cancer patients with a positive family history. Ann Surg Oncol 9:912-9, 11/2002. PMID: 12417515.
57. Solorzano CC, Middleton LP, Hunt KK, Mirza N, Meric F, Kuerer HM, Ross MI, Ames FC, Feig BW, Pollock RE, Singletary SE, Babiera G. Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg 184:364-8, 10/2002. PMID: 12383904.
58. Bouvet M, Ollila DW, Hunt KK, Babiera GV, Spitz FR, Giuliano AE, Strom EA, Ames FC, Ross MI, Singletary SE. Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol 4:650-4, 12/1997. PMID: 9416413.
59. Bouvet M, Babiera GV, Tucker S, Singletary SE. Does breast conservation therapy in young women with breast cancer adversely affect local disease control and survival? The MD Anderson Cancer Center Experience. The Breast Journal 3:169-75, 7/1997.
60. Bouvet M, Babiera GV, Termuhlen PM, Hester JP, Kantarjian HM, Pollock RE. Splenectomy in the accelerated or blastic phase of chronic myelogenous leukemia: a single-institution, 25-year experience. Surgery 122:20-5, 7/1997. PMID: 9225910.
61. Hurd TC, Sneige N, Allen PK, Strom EA, McNeese MD, Babiera GV, Singletary SE. Impact of extensive intraductal component on recurrence and survival in patients with stage I or II breast cancer treated with breast conservation therapy. Ann Surg Oncol 4(2):119-24, 3/1997. PMID: 9084847.

Invited Articles

1. Babiera GV, Khan SA. Treatment of Stage IV Breast Cancer with Intact Primary - A Case for Resection? Current Breast Cancer Reports 4(2):153-160, 3/2012.
2. Ching CD, Babiera GV. Mammography a Viable Option for Healthy Women as They Age. ACP Internist, 1/2009.
3. Babiera GV. Metastatic Breast Cancer: A Paradigm Shift Toward a More Aggressive Approach. Cancer J 15(1):78, Jan-Feb, 1/2009. PMID: 19197179.
4. Lang JE, Babiera GV. Locoregional Resection in Stage IV Breast Cancer: Tumor Biology, Molecular and Clinical Perspectives. Surg Clin North Am 87(2)(2):527-538, 4/2007. PMID: 17498542.
5. Babiera GV. Surgical Considerations for Breast Conserving Therapy in Patients Undergoing Neoadjuvant Chemotherapy for Early-Stage Breast Cancer. Br Ca Online 8(2), www.bco.org, 2005.
6. Meric-Bernstam F, Mirza NQ, Vlastos GV, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese MD, Strom EA, Valero V, Hunt KK. Impact of Positive Surgical Margins and Ipsilateral Breast Tumor Recurrence on Disease-Specific Survival After Breast-Conserving Therapy. The American Journal of Oncology Review 2:428-433, 2003.

Editorials

1. Babiera GV. Surgery of the intact primary tumor for patients presenting with metastatic breast cancer: Palliation or cure? Breast Diseases: A Year Book Quarterly 17(3):217-218, 10/2006.

Abstracts

1. Akay CL, Meric-Bernstam F, Hunt KK, Grubbs EG, Bedrosian I, Tucker SL, Kuerer HM, Hoffman KE, Babiera GV, Strom EA, Buchholz TA, Mittendorf EA. Evaluation of the MD Anderson prognostic index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy. Ann Surg Oncol 19(3):901-7, 3/2012. e-Pub 8/2011. PMID: 21861223.
2. Sharma R, Bedrosian I, Lucci A, Hwang RF, Rourke LL, Qiao W, Buchholz TA, Kronowitz SJ, Krishnamurthy S, Babiera GV, Gonzalez-Angulo AM, Meric-Bernstam F, Mittendorf EA, Hunt KK, Kuerer HM. Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy. Ann Surg Oncol 17(11):2899-908, 11/2010. e-Pub 5/2010. PMID: 20443145.
3. Kang T, Yi M, Hunt KK, Mittendorf EA, Babiera GV, Kuerer H, Bedrosian I, Hwang RF, Lucci A, Meric-Bernstam F. Does blue dye contribute to success of sentinel node mapping for breast cancer?. Ann Surg Oncol 17(Suppl 3):280-5, 10/2010. e-Pub 9/2010. PMID: 20853047.
4. Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do KA, Kuerer HM, Babiera GV, Mittendorf EA, Ready K, Litton J, Meric-Bernstam F. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila) 3(8):1026-34, 8/2010. e-Pub 7/2010. PMID: 20647335.
5. Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, Krishnamurthy S, Meric-Bernstam F. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer 116(11):2543-8, 6/2010. PMID: 20336790.
6. Brown AS, Hunt KK, Shen J, Huo L, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Boughey JC, Ching CD, Gilcrease MZ. Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment. Cancer 116(12):2878-83, 6/2010. PMID: 20564394.
7. Fearmonti RM, Batista LI, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Eva Singletary S, Babiera GV. False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burden. Breast J 15(6):645-8, Nov-Dec, 11/2009. e-Pub 9/2009. PMID: 19735388.
8. Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I, Hwang RF, Kuerer HM, Ross MI, Meric-Bernstam F. Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg 250(4):558-66, 10/2009. e-Pub 8/2009. PMID: 19730235.
9. Boughey JC, Wagner J, Garrett BJ, Harker L, Middleton LP, Babiera GV, Meric-Bernstam F, Lucci A, Hunt KK, Bedrosian I. Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation. Ann Surg Oncol 16(6):1606-11, 6/2009. e-Pub 3/2009. PMID: 19280264.
10. Yi M, Meric-Bernstam F, Middleton LP, Arun BK, Bedrosian I, Babiera GV, Hwang RF, Kuerer HM, Yang W, Hunt KK. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer 115(5):962-71, 3/2009. PMID: 19172584.
11. Mittendorf EA, Sahin AA, Tucker SL, Meric-Bernstam F, Yi M, Nayeemuddin KM, Babiera GV, Ross MI, Feig BW, Kuerer HM, Hunt KK. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol 15(12):3369-77, 12/2008. e-Pub 9/2008. PMID: 18815841.
12. Yi M, Meric-Bernstam F, Ross MI, Akins JS, Hwang RF, Lucci A, Kuerer HM, Babiera GV, Gilcrease MZ, Hunt KK. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?. Cancer 113(1):30-37, 7/2008. PMID: 18457326.
13. Rao R, Feng L, Kuerer HM, Singletary SE, Bedrosian I, Hunt KK, Ross MI, Hortobagyi GN, Feig BW, Ames FC, Babiera GV. Timing of Surgical Intervention for The Intact Primary in Stage IV Breast Cancer Patients. Ann Surg Oncol 15(6):1696-702, 6/2008. e-Pub 3/2008. PMID: 18357493.
14. Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, Perkins GH, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Akins JS, Hunt KK. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg 194(4):527-31, 10/2007. PMID: 17826073.
15. Boughey JC, Middleton LP, Harker L, Garrett B, Fornage B, Hunt KK, Babiera GV, Dempsey P, Bedrosian I. Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast. Am J Surg 194(4):450-5, 10/2007. PMID: 17826054.
16. Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KK. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110(4):723-30, 8/2007. PMID: 17587208.
17. Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109(7):1255-63, 4/2007. PMID: 17330229.
18. Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA, Meric-Bernstam F. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol 14(4):1458-71, 4/2007. e-Pub 1/2007. PMID: 17260108.

Book Chapters

1. Gilcrease MZ, Babiera GV, Hennessy BT, Woodward WA. Metaplastic Carcinoma of the Breast. In: Advanced Therapy of Breast Disease, 3rd Edition. Ed(s) Babiera GV, Skoracki RJ, Esteva FJ. People's Medical Publishing House: Shelton, CT, 1119-32, 2012.
2. Caudle AS, Babiera GV. Primary Tumor Extirpation in Stage IV Disease: Surgical Considerations. In: Advanced Therapy of Breast Disease, 3rd Edition. Ed(s) Babiera GV, Skoracki RJ, Esteva FJ. People's Medical Publishing House: Shelton, CT, 1001-8, 2012.
3. Rao R, Babiera GV. Selection Criteria for Breast Conservation. In: Advanced Therapy of Breast Disease, 3rd Edition. Ed(s) Babiera GV, Skoracki RJ, Esteva FJ. People's Medical Publishing House: Shelton, CT, 511-5, 2012.
4. Negron-Gonzalez V, Oh JL, Cristofanilli M, Babiera GV. Inflammatory Breast Cancer. In: Kuerer's Breast Surgical Oncology, 1st Edition. Ed(s) Kuerer HM. McGraw-Hill: USA, 927-35, 2010.
5. Caudle AS, Babiera GV,. Management of Recurrent and Disseminated Breast Cancer. In: Cameron's Current Surgical Therapy, 10th Edition. Ed(s) Cameron JL, Cameron AM. Elsevier Saunders: Philadelphia, PA, 952-6, 2010.
6. Mendez J, Singletary SE, Babiera GV. Surgery in Patients with Stage IV Metastatic Breast Cancer. In: Kuerer’s Breast Surgical Oncology, 1st Edition. Ed(s) Kuerer HM. McGraw-Hill: USA, 753-8, 2010.
7. Al-Rafaie W, Middleton L, Strom EA, Babiera GV. Surgical Management of Axillary Metastases from Occult Primary Breast Cancer. In: Advanced Therapy in Surgical Oncology. Ed(s) Pollock RE, Ross MI, Curley SA, Perrier ND. Peoples Medical Publishing House-USA: USA, 543-48, 2008.
8. Hennessy BT, Gilcrease MZ, Babiera GV, Yang W, Valero V, Hortobagyi GN. Carcinosarcoma of the Breast. In: Textbook of Uncommon Cancers, 3rd Edition. Ed(s) D Raghavan, ML Brecher, DH Johnson, NJ Meropol, PL Moots, PG Rose, IA Mayer. John Wiley & Sons Ltd. Chichester, UK, 218-28, 2006.
9. Zager J, Solorzano CC, Thomas E, Feig BW, Babiera GV. Invasive Breast Cancer. In: The MD Anderson Surgical Oncology Handbook, 4th Edition. Ed(s) Feig BW, Berger DH, Fuhrman GM. Lippincott Williams and Wilkins: Philadelphia, PA, 23-59, 2005.
10. Babiera GV. Breast Conservation Therapy: Selection Criteria. In: Advanced Therapy of Breast Disease, 2nd Edition. Ed(s) Singletary SE, Robb GL, Hortobagyi G. BC Decker Inc. London, 330-340, 2004.
11. Chagpar A, Babiera GV. Mastitis and Breast Abscess. In: Problems in General Surgery. 20(4), 2003.
12. Scaife C, Babiera GV. The Approach to Breast Cancer. In: Case Files in General Surgery, 3rd Edition. Ed(s) Johnson CA, Yoo C. McGraw-Hill and Lange Medical Books: New York, NY, 16-24, 2003.
13. Scaife C, Babiera GV. The Approach to the High-Risk Patient with Breast Cancer. In: Case Files in General Surgery, 3rd Edition. Ed(s) Johnson CA, Yoo C. McGraw-Hill and Lange Medical Books: New York, NY, 104-110, 2003.

Books (edited and written)

1. Babiera, GV. Ed(s) Skoracki R, Esteva F. Advanced Therapy of Breast Disease, 3rd Edition. People’s Medical Publishing House - USA: Connecticut, 2012.

Letters to the Editor

1. Rao R, Babiera GV. Author reply: Surgery in stage iv breast cancer patients: continued controversy. Ann Surg Oncol 16(5):1441, 5/2009.
2. Raut CP, Daley D, Hunt KK, Akins J, Ross MI, Singletary SE, Marshall GD, Meric-Bernstam F, Babiera GV, Feig BW, Ames FC, Kuerer HM. Anaphylactoid Reactions to Isosulfan Blue Dye during Breast Cancer Lymphatic Mapping in Patients Given Preoperative Prophylaxis. J Clin Oncol 22:567-8, 2/2004.

Last updated: 7/31/2014